• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Monday, July 7, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

MICROB-PREDICT — €15 million EU funded microbiome research project kicks off

Bioengineer by Bioengineer
February 1, 2019
in Health
Reading Time: 3 mins read
0
ADVERTISEMENT
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Developing personalised targets for treatment of decompensated cirrhosis and acute-on-chronic liver failure (ACLF)

Barcelona, Spain, 1 February 2019 – An EU Horizon 2020-financed project investigating methods to better understand the role of the microbiome to help stratify patient health care and treatment of decompensated cirrhosis and ACLF officially commenced last month. The innovative endeavour, known as MICROB-PREDICT, involves a 22-member multinational and multidisciplinary consortium of world-leading microbiome specialists, clinical experts, and patient organisations. MICROB-PREDICT is an acronym for “MICROBiome-based biomarkers to PREDICT decompensation of liver cirrhosis and treatment response”. Cirrhosis is the cause of 1.2 million deaths worldwide annually . It is estimated that less than 10% of ongoing studies in the field are focused on decompensated cirrhosis and ACLF . As a result, treatment options for patients are lacking considerably.

MICROB-PREDICT & the gut-liver-axis

The microbiome plays a critical role in the development and severity of cirrhosis, which is a major cause of morbidity and mortality worldwide. “One of our aims is to find the microbiome signatures of decompensation of cirrhosis and predict the development of ACLF. Moreover, this project will develop point-of-care devices to predict the response to specific treatments in these patients. The project has the potential to change the clinical practice towards more personalized medicine,” says Prof. Jonel Trebicka, scientific coordinator of the MICROB-PREDICT consortium.

Potential for new treatment strategies

The project will base the development of biomarkers on high-quality data from three existing EU-funded projects (GALAXY, LIVERHOPE, and PREDICT). The knowledge gained throughout the 75 month project will contribute to the development of improved and potentially personalized therapies for patients suffering from cirrhosis and ACLF. A basic website about the project is already online (http://www.microb-predict.eu), and a more extensive project website will be launched in the coming months.

The 22 partners in the MICROB-PREDICT consortium coordinated by EF-CLIF are:

  • Academisch Ziekenhuis Leiden (Leiden University Medical Center) (LUMC)

  • Biobyte Solutions GmbH (Biobyte)

  • Commissariat à l’Energie Atomique et aux Energies Alternatives (CEA)

  • concentris research management GmbH (concentris)

  • Debreceni Egyetem (University of Debrecen) (UNIDEB)

  • European Association For The Study of the Liver (EASL)

  • European Foundation For The Study of Chronic Liver Failure (EF-CLIF)

  • European Liver Patients Association (ELPA)

  • European Molecular Biology Laboratory (EMBL)

  • Fundacio Clinic Per A La Recerca Biomedica (FCRB)

  • Fundacio Institut Catala De Nanociencia i Nanotecnologia (ICN2)

  • Institut National De La Recherche Agronomique (INRA)

  • Johann Wolfgang Goethe-Universität Frankfurt Am Main (GUF)

  • Katholieke Universiteit Leuven (KU Leuven)

  • King’s College London (KCL)

  • Max-Planck-Gesellschaft zur Foerderung der Wissenschaften e.V. (MPG)

  • Odense Universitetshospital (OUH)

  • Universitat de Barcelona (UB)

  • Universitetet I Oslo (UiO)

  • University College London (UCL)

  • University of Copenhagen (UCPH)

  • Vaiomer SAS (Vaiomer)

###

1 – Murray CJ, Atkinson C, Bhalla K, Birbeck G, Burstein R, Chou D, et al (2013). The state of US health, 1990-2010: burden of diseases, injuries, and risk factors. JAMA; 310: 591-608.

2 – Zutshi Y (2015). Liver Disease Treatments: The Global Market. BBC Research; PHM057C.

Media Contact
Margaret Walker
[email protected]
44-077-471-21175
https://mailchi.mp/easloffice/press-release-microbpredict-01022019

Tags: GastroenterologyInternal MedicineLiverMedicine/Health
Share12Tweet8Share2ShareShareShare2

Related Posts

blank

Evolving Deaminase Hotspots for Precise Cytosine Editing

July 7, 2025
Linking Body, Behavior to Atherogenic Risk Ratio

Linking Body, Behavior to Atherogenic Risk Ratio

July 5, 2025

FGF13 Shields Neurons to Halt Age-Related Hearing Loss

July 5, 2025

Glucose Metabolism Controls CD4+ T Cell Fate

July 5, 2025
Please login to join discussion

POPULAR NEWS

  • Zheng-Rong Lu

    Pancreatic Cancer Vaccines Eradicate Disease in Preclinical Studies

    74 shares
    Share 30 Tweet 19
  • Enhancing Broiler Growth: Mannanase Boosts Performance with Reduced Soy and Energy

    72 shares
    Share 29 Tweet 18
  • AI Achieves Breakthrough in Drug Discovery by Tackling the True Complexity of Aging

    69 shares
    Share 28 Tweet 17
  • New Organic Photoredox Catalysis System Boosts Efficiency, Drawing Inspiration from Photosynthesis

    54 shares
    Share 22 Tweet 14

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Evolving Deaminase Hotspots for Precise Cytosine Editing

HIV-1 Nuclear Entry Hinges on Capsid and Pore

Soil Dryness: Timing and Impact on Photosynthesis

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.